Get the Stockscreener App
10.21
0.29%
0.03
Zevra Therapeutics Inc stock is traded at $10.21, with a volume of 2.87M.
It is up +0.29% in the last 24 hours and up +4.72% over the past month.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
See More
Previous Close:
$10.18
Open:
$10.16
24h Volume:
2.87M
Relative Volume:
1.54
Market Cap:
$573.14M
Revenue:
$27.46M
Net Income/Loss:
$-46.05M
P/E Ratio:
-7.9147
EPS:
-1.29
Net Cash Flow:
$-33.83M
1W Performance:
-7.85%
1M Performance:
+4.72%
6M Performance:
+27.63%
1Y Performance:
+21.55%
1-Day Range:
$9.67
$10.26
1-Week Range:
$9.67
$11.24
52-Week Range:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Name
Zevra Therapeutics Inc
Sector
Industry
Phone
(321) 939-3416
Address
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Compare ZVRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
10.21 | 571.46M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-08-25 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-07-24 | Initiated | Guggenheim | Buy |
| Sep-24-24 | Initiated | JMP Securities | Mkt Outperform |
| Sep-24-24 | Reiterated | Maxim Group | Buy |
| Apr-02-24 | Reiterated | Maxim Group | Buy |
| Mar-12-24 | Initiated | William Blair | Outperform |
| Mar-17-23 | Initiated | Maxim Group | Buy |
View All
Zevra Therapeutics Inc Stock (ZVRA) Latest News
Will Zevra Therapeutics Inc. bounce back from current supportWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
How sentiment analysis helps forecast Zevra Therapeutics Inc.Oil Prices & Weekly Stock Performance Updates - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Q2 2025 Zevra Therapeutics Inc Earnings Call Transcript - GuruFocus
Technical signs of recovery in Zevra Therapeutics Inc.Portfolio Profit Report & Expert Verified Movement Alerts - newser.com
Is this a good reentry point in Zevra Therapeutics Inc.Oil Prices & Weekly Top Gainers Trade List - newser.com
How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorWeekly Market Report & Safe Entry Point Identification - newser.com
Zevra Therapeutics (NASDAQ:ZVRA) Is Using Debt Safely - simplywall.st
Can Zevra Therapeutics Inc. stock beat market expectations this quarterDip Buying & Safe Swing Trade Setups - newser.com
What the charts say about Zevra Therapeutics Inc. today2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Pattern recognition hints at Zevra Therapeutics Inc. upside2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com
Can Zevra Therapeutics Inc. rally from current levelsJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
How risky is Zevra Therapeutics Inc. stock nowJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock draw ESG focused fundsMarket Sentiment Summary & Precise Swing Trade Alerts - newser.com
ZVRA (Zevra Therapeutics) Days Inventory : 13.52 (As of Jun. 2025) - GuruFocus
Why Zevra Therapeutics Inc. stock is in analyst buy zoneWeekly Stock Analysis & Daily Stock Trend Reports - newser.com
Is Zevra Therapeutics Inc. showing signs of accumulationOptions Play & AI Powered Market Entry Strategies - newser.com
Will Zevra Therapeutics Inc. stock outperform growth indexes2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock beat international competitionWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Analyzing Zevra Therapeutics Inc. with risk reward ratio chartsEarnings Recap Report & Weekly High Conviction Ideas - newser.com
Using Bollinger Bands to evaluate Zevra Therapeutics Inc.Market Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Zevra Therapeutics exec sells $23,587 in stock - MSN
Visualizing Zevra Therapeutics Inc. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
Zevra Therapeutics, Inc. (ZVRA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic value2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Zevra Therapeutics Inc Stock (ZVRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):